[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Interleukin 17A Market Report 2018

January 2018 | 104 pages | ID: UA658457E66EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Interleukin 17A market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Interleukin 17A in these regions, from 2013 to 2025 (forecast).
United States Interleukin 17A market competition by top manufacturers/players, with Interleukin 17A sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • AbbVie Inc
  • Abeome Corporation
  • Affibody AB
  • Cell Medica Limited
  • Eli Lilly and Company
  • Johnson & Johnson
  • Merck KGaA
  • Novartis AG
  • Orega Biotech SAS
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • ABY-035
  • CNTO-6785
  • DLX-2882
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Chronic Pain
  • Liver Cancer
  • Kidney Cancer
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Interleukin 17A Market Report 2018

1 INTERLEUKIN 17A OVERVIEW

1.1 Product Overview and Scope of Interleukin 17A
1.2 Classification of Interleukin 17A by Product Category
  1.2.1 United States Interleukin 17A Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Interleukin 17A Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 ABY-035
  1.2.4 CNTO-6785
  1.2.5 DLX-2882
  1.2.6 Others
1.3 United States Interleukin 17A Market by Application/End Users
  1.3.1 United States Interleukin 17A Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Chronic Pain
  1.3.3 Liver Cancer
  1.3.4 Kidney Cancer
  1.3.5 Others
1.4 United States Interleukin 17A Market by Region
  1.4.1 United States Interleukin 17A Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Interleukin 17A Status and Prospect (2013-2025)
  1.4.3 Southwest Interleukin 17A Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Interleukin 17A Status and Prospect (2013-2025)
  1.4.5 New England Interleukin 17A Status and Prospect (2013-2025)
  1.4.6 The South Interleukin 17A Status and Prospect (2013-2025)
  1.4.7 The Midwest Interleukin 17A Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Interleukin 17A (2013-2025)
  1.5.1 United States Interleukin 17A Sales and Growth Rate (2013-2025)
  1.5.2 United States Interleukin 17A Revenue and Growth Rate (2013-2025)

2 UNITED STATES INTERLEUKIN 17A MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Interleukin 17A Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Interleukin 17A Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Interleukin 17A Average Price by Players/Suppliers (2013-2018)
2.4 United States Interleukin 17A Market Competitive Situation and Trends
  2.4.1 United States Interleukin 17A Market Concentration Rate
  2.4.2 United States Interleukin 17A Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Interleukin 17A Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES INTERLEUKIN 17A SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Interleukin 17A Sales and Market Share by Region (2013-2018)
3.2 United States Interleukin 17A Revenue and Market Share by Region (2013-2018)
3.3 United States Interleukin 17A Price by Region (2013-2018)

4 UNITED STATES INTERLEUKIN 17A SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Interleukin 17A Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Interleukin 17A Revenue and Market Share by Type (2013-2018)
4.3 United States Interleukin 17A Price by Type (2013-2018)
4.4 United States Interleukin 17A Sales Growth Rate by Type (2013-2018)

5 UNITED STATES INTERLEUKIN 17A SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Interleukin 17A Sales and Market Share by Application (2013-2018)
5.2 United States Interleukin 17A Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES INTERLEUKIN 17A PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 AbbVie Inc
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Interleukin 17A Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 AbbVie Inc Interleukin 17A Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Abeome Corporation
  6.2.2 Interleukin 17A Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Abeome Corporation Interleukin 17A Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Affibody AB
  6.3.2 Interleukin 17A Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Affibody AB Interleukin 17A Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Cell Medica Limited
  6.4.2 Interleukin 17A Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Cell Medica Limited Interleukin 17A Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Eli Lilly and Company
  6.5.2 Interleukin 17A Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Eli Lilly and Company Interleukin 17A Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Johnson & Johnson
  6.6.2 Interleukin 17A Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Johnson & Johnson Interleukin 17A Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Merck KGaA
  6.7.2 Interleukin 17A Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Merck KGaA Interleukin 17A Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Novartis AG
  6.8.2 Interleukin 17A Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Novartis AG Interleukin 17A Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Orega Biotech SAS
  6.9.2 Interleukin 17A Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Orega Biotech SAS Interleukin 17A Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview

7 INTERLEUKIN 17A MANUFACTURING COST ANALYSIS

7.1 Interleukin 17A Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Interleukin 17A

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Interleukin 17A Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Interleukin 17A Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES INTERLEUKIN 17A MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Interleukin 17A Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Interleukin 17A Sales Volume Forecast by Type (2018-2025)
11.3 United States Interleukin 17A Sales Volume Forecast by Application (2018-2025)
11.4 United States Interleukin 17A Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Interleukin 17A
Figure United States Interleukin 17A Market Size (K Pcs) by Type (2013-2025)
Figure United States Interleukin 17A Sales Volume Market Share by Type (Product Category) in 2017
Figure ABY-035 Product Picture
Figure CNTO-6785 Product Picture
Figure DLX-2882 Product Picture
Figure Others Product Picture
Figure United States Interleukin 17A Market Size (K Pcs) by Application (2013-2025)
Figure United States Sales Market Share of Interleukin 17A by Application in 2017
Figure Chronic Pain Examples
Table Key Downstream Customer in Chronic Pain
Figure Liver Cancer Examples
Table Key Downstream Customer in Liver Cancer
Figure Kidney Cancer Examples
Table Key Downstream Customer in Kidney Cancer
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Interleukin 17A Market Size (Million USD) by Region (2013-2025)
Figure The West Interleukin 17A Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Interleukin 17A Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Interleukin 17A Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Interleukin 17A Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Interleukin 17A Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Interleukin 17A Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Interleukin 17A Sales (K Pcs) and Growth Rate (2013-2025)
Figure United States Interleukin 17A Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Interleukin 17A Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table United States Interleukin 17A Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table United States Interleukin 17A Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Interleukin 17A Sales Share by Players/Suppliers
Figure 2017 United States Interleukin 17A Sales Share by Players/Suppliers
Figure United States Interleukin 17A Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Interleukin 17A Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Interleukin 17A Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Interleukin 17A Revenue Share by Players/Suppliers
Figure 2017 United States Interleukin 17A Revenue Share by Players/Suppliers
Table United States Market Interleukin 17A Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018)
Figure United States Market Interleukin 17A Average Price (USD/Pcs) of Key Players/Suppliers in 2017
Figure United States Interleukin 17A Market Share of Top 3 Players/Suppliers
Figure United States Interleukin 17A Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Interleukin 17A Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Interleukin 17A Product Category
Table United States Interleukin 17A Sales (K Pcs) by Region (2013-2018)
Table United States Interleukin 17A Sales Share by Region (2013-2018)
Figure United States Interleukin 17A Sales Share by Region (2013-2018)
Figure United States Interleukin 17A Sales Market Share by Region in 2017
Table United States Interleukin 17A Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Interleukin 17A Revenue Share by Region (2013-2018)
Figure United States Interleukin 17A Revenue Market Share by Region (2013-2018)
Figure United States Interleukin 17A Revenue Market Share by Region in 2017
Table United States Interleukin 17A Price (USD/Pcs) by Region (2013-2018)
Table United States Interleukin 17A Sales (K Pcs) by Type (2013-2018)
Table United States Interleukin 17A Sales Share by Type (2013-2018)
Figure United States Interleukin 17A Sales Share by Type (2013-2018)
Figure United States Interleukin 17A Sales Market Share by Type in 2017
Table United States Interleukin 17A Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Interleukin 17A Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Interleukin 17A by Type (2013-2018)
Figure Revenue Market Share of Interleukin 17A by Type in 2017
Table United States Interleukin 17A Price (USD/Pcs) by Types (2013-2018)
Figure United States Interleukin 17A Sales Growth Rate by Type (2013-2018)
Table United States Interleukin 17A Sales (K Pcs) by Application (2013-2018)
Table United States Interleukin 17A Sales Market Share by Application (2013-2018)
Figure United States Interleukin 17A Sales Market Share by Application (2013-2018)
Figure United States Interleukin 17A Sales Market Share by Application in 2017
Table United States Interleukin 17A Sales Growth Rate by Application (2013-2018)
Figure United States Interleukin 17A Sales Growth Rate by Application (2013-2018)
Table AbbVie Inc Basic Information List
Table AbbVie Inc Interleukin 17A Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure AbbVie Inc Interleukin 17A Sales Growth Rate (2013-2018)
Figure AbbVie Inc Interleukin 17A Sales Market Share in United States (2013-2018)
Figure AbbVie Inc Interleukin 17A Revenue Market Share in United States (2013-2018)
Table Abeome Corporation Basic Information List
Table Abeome Corporation Interleukin 17A Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Abeome Corporation Interleukin 17A Sales Growth Rate (2013-2018)
Figure Abeome Corporation Interleukin 17A Sales Market Share in United States (2013-2018)
Figure Abeome Corporation Interleukin 17A Revenue Market Share in United States (2013-2018)
Table Affibody AB Basic Information List
Table Affibody AB Interleukin 17A Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Affibody AB Interleukin 17A Sales Growth Rate (2013-2018)
Figure Affibody AB Interleukin 17A Sales Market Share in United States (2013-2018)
Figure Affibody AB Interleukin 17A Revenue Market Share in United States (2013-2018)
Table Cell Medica Limited Basic Information List
Table Cell Medica Limited Interleukin 17A Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Cell Medica Limited Interleukin 17A Sales Growth Rate (2013-2018)
Figure Cell Medica Limited Interleukin 17A Sales Market Share in United States (2013-2018)
Figure Cell Medica Limited Interleukin 17A Revenue Market Share in United States (2013-2018)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Interleukin 17A Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Eli Lilly and Company Interleukin 17A Sales Growth Rate (2013-2018)
Figure Eli Lilly and Company Interleukin 17A Sales Market Share in United States (2013-2018)
Figure Eli Lilly and Company Interleukin 17A Revenue Market Share in United States (2013-2018)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Interleukin 17A Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Johnson & Johnson Interleukin 17A Sales Growth Rate (2013-2018)
Figure Johnson & Johnson Interleukin 17A Sales Market Share in United States (2013-2018)
Figure Johnson & Johnson Interleukin 17A Revenue Market Share in United States (2013-2018)
Table Merck KGaA Basic Information List
Table Merck KGaA Interleukin 17A Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Merck KGaA Interleukin 17A Sales Growth Rate (2013-2018)
Figure Merck KGaA Interleukin 17A Sales Market Share in United States (2013-2018)
Figure Merck KGaA Interleukin 17A Revenue Market Share in United States (2013-2018)
Table Novartis AG Basic Information List
Table Novartis AG Interleukin 17A Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Novartis AG Interleukin 17A Sales Growth Rate (2013-2018)
Figure Novartis AG Interleukin 17A Sales Market Share in United States (2013-2018)
Figure Novartis AG Interleukin 17A Revenue Market Share in United States (2013-2018)
Table Orega Biotech SAS Basic Information List
Table Orega Biotech SAS Interleukin 17A Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Orega Biotech SAS Interleukin 17A Sales Growth Rate (2013-2018)
Figure Orega Biotech SAS Interleukin 17A Sales Market Share in United States (2013-2018)
Figure Orega Biotech SAS Interleukin 17A Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Interleukin 17A
Figure Manufacturing Process Analysis of Interleukin 17A
Figure Interleukin 17A Industrial Chain Analysis
Table Raw Materials Sources of Interleukin 17A Major Players/Suppliers in 2017
Table Major Buyers of Interleukin 17A
Table Distributors/Traders List
Figure United States Interleukin 17A Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Interleukin 17A Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Interleukin 17A Price (USD/Pcs) Trend Forecast (2018-2025)
Table United States Interleukin 17A Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Interleukin 17A Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Interleukin 17A Sales Volume (K Pcs) Forecast by Type in 2025
Table United States Interleukin 17A Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Interleukin 17A Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Interleukin 17A Sales Volume (K Pcs) Forecast by Application in 2025
Table United States Interleukin 17A Sales Volume (K Pcs) Forecast by Region (2018-2025)
Table United States Interleukin 17A Sales Volume Share Forecast by Region (2018-2025)
Figure United States Interleukin 17A Sales Volume Share Forecast by Region (2018-2025)
Figure United States Interleukin 17A Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


More Publications